4/22
Coronavirus Research
Perceptions shaped social behavior during the pandemic
Research from Penn psychologists found that Americans who most feared losing their connections continued interacting with others, paradoxically acting in ways that risked prolonging disease-mitigating social restrictions.
Inspiring people, place, and purpose
Penn President Amy Gutmann’s record tenure of nearly 18 years is the University’s most transformative.
New antiviral drug combination is highly effective against SARS-CoV-2
A Penn Medicine study finds that combining remdesivir or molnupiravir with the experimental drug brequinar blocked the replication of the virus that causes COVID-19 in lung cells.
It takes a village, especially during a global pandemic
A Penn LDI and Penn Population Aging Research Center team tracks behavior and attitudes in Malawi during COVID-19’s first wave.
Mask-wearing and moral values
Tiffany Tieu led a study on the psychology of mask-wearing and its relationship with a person’s moral values, using Penn undergraduates as the subjects.
Catching up with omicron
The Perelman School of Medicine’s Frederic Bushman and Susan Weiss share what they and other scientists are learning about the new, dominant variant of SARS-CoV-2.
From foundational discoveries to profound impact
How decades of mRNA research at Penn made powerful new COVID-19 vaccines possible—and opened a new vista for future discoveries.
Millions embrace COVID-19 misinformation, which is linked to vaccine hesitancy
Millions continue to believe misinformation about vaccination and COVID-19, and these beliefs are associated with hesitancy to get themselves and their children vaccinated—or, if they are vaccinated, to get a booster for added protection.
In Peru and the U.S., considering the factors that drive public health
By comparing and contrasting the two nations’ approaches to controlling infectious diseases, students in Parallel Plagues deepened their appreciation of how these diseases emerge, cause harm, and might be effectively controlled.
The COVID landscape after a year with vaccines
In a conversation hosted by LDI, experts from Penn, the Black Doctors COVID-19 Consortium, and the Coalition for Epidemic Preparedness Innovations discussed the vaccine rollout, boosters, misinformation, and more.
In the News
The mRNA miracle workers
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
Review of COVID death stats finds likely undercount in official numbers
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
The Franklin Institute honors nine scientists and engineers on its 200th anniversary
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
Long COVID brain fog may originate in a surprising place, say scientists
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
Long COVID research is in its ‘most hopeful’ phase yet
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →